Impact of a pharmaceutical care programme on health-related quality of life among women with epilepsy: a randomised controlled trial (IPHIWWE study).
Open Access
- 31 October 2014
- journal article
- pragmatic clinical-trial
- Published by Springer Science and Business Media LLC in Health and Quality of Life Outcomes
- Vol. 12 (1), 162
- https://doi.org/10.1186/s12955-014-0162-8
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- The quality of life of people with epilepsy at a tertiary referral centre in MalaysiaHealth and Quality of Life Outcomes, 2013
- Patient Reported Outcome (PRO) assessment in epilepsy: a review of epilepsy-specific PROs according to the Food and Drug Administration (FDA) regulatory requirementsHealth and Quality of Life Outcomes, 2013
- An exploratory study of primary care pharmacist-led epilepsy consultationsInternational Journal of Pharmacy Practice, 2012
- Defining minimally important change in QOLIE-31 scores: Estimates from three placebo-controlled lacosamide trials in patients with partial-onset seizuresEpilepsy & Behavior, 2012
- Determinants of quality of life in people with epilepsy and their gender differencesEpilepsy & Behavior, 2011
- Health-Related Quality of Life after Ischemic Stroke: The Impact of Pharmaceutical Interventions on Drug Therapy (Pharmaceutical Care Concept)Health and Quality of Life Outcomes, 2010
- Factors associated with impaired quality of life in younger and older adults with epilepsyEpilepsy Research, 2009
- Antiepileptic drugs—best practice guidelines for therapeutic drug monitoring: A position paper by the subcommission on therapeutic drug monitoring, ILAE Commission on Therapeutic StrategiesEpilepsia, 2008
- A comparison of health-related quality of life in patients with epilepsy, diabetes and multiple sclerosisEpilepsy Research, 1996
- Concurrent and Predictive Validity of a Self-reported Measure of Medication AdherenceMedical Care, 1986